Loading…
Lobbying Income
$80.4M
Filings
1,717
Unique Clients
33
Active Period
2004–2026
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Foster Care Stabilization Act
2026 · third_quarter · Client: BRISTOL-MYERS SQUIBB
Policies related to the Most Favored Nation Drug Pricing Model Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R.4299 - Protecting Patient Access to Cancer and Complex Therapies Act Issues related to Center for Medicare and Medicaid Innovation (CMMI) guardrails Issues related to CMS fixed-dose combination drugs for Initial Price Applicability Year 2029 (CMS-4215-P)
Client expense: — · Firm income: $80,000
Matched citations: H.R.4299
To amend title XVIII of the Social Security Act to limit the coinsurance amount for certain services furnished in an ambulatory surgical center.
2026 · third_quarter · Client: zimmer biomet
Access and reimbursement of medical devices in Medicare program. Issues related to capping beneficiary copayments for Medicare beneficiaries in ambulatory surgery centers, included in Medicare Beneficiary Co-Pay Fairness Act of 2025(H.R. 3006/S. 1776) The Ensuring Patient Access to Critical Breakthrough Products Act (H.R. 5343/S. 1717)
Client expense: — · Firm income: $50,000
Matched citations: H.R. 3006
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · third_quarter · Client: zimmer biomet
Access and reimbursement of medical devices in Medicare program. Issues related to capping beneficiary copayments for Medicare beneficiaries in ambulatory surgery centers, included in Medicare Beneficiary Co-Pay Fairness Act of 2025(H.R. 3006/S. 1776) The Ensuring Patient Access to Critical Breakthrough Products Act (H.R. 5343/S. 1717)
Client expense: — · Firm income: $50,000
Matched citations: H.R. 5343
Issues related to Artificial Intelligences approval in Medical Devices. Issues related to The SECURE Data Act (H.R. 8413).
Client expense: — · Firm income: $50,000
Matched citations: H.R. 8413
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
2026 · third_quarter · Client: zimmer biomet
Access and reimbursement of medical devices in Medicare program. Issues related to capping beneficiary copayments for Medicare beneficiaries in ambulatory surgery centers, included in Medicare Beneficiary Co-Pay Fairness Act of 2025(H.R. 3006/S. 1776) The Ensuring Patient Access to Critical Breakthrough Products Act (H.R. 5343/S. 1717)
Client expense: — · Firm income: $50,000
Matched citations: S. 1717
Medicare Beneficiary Co-Pay Fairness Act
2026 · third_quarter · Client: zimmer biomet
Access and reimbursement of medical devices in Medicare program. Issues related to capping beneficiary copayments for Medicare beneficiaries in ambulatory surgery centers, included in Medicare Beneficiary Co-Pay Fairness Act of 2025(H.R. 3006/S. 1776) The Ensuring Patient Access to Critical Breakthrough Products Act (H.R. 5343/S. 1717)
Client expense: — · Firm income: $50,000
Matched citations: S. 1776
Issues related to making Health Savings Accounts and Health Reimbursement Arrangements more accessible and ubiquitous, including H.R. 548- HSA Modernization Act, H.R.919 - Chronic Disease Flexible Coverage Act, S. 2875 - Custom Health Option and Individual Care Expense (CHOICE) Act, H.R. 5463 - Choice Arrangement Act, S.2875 - CHOICE Act
Client expense: — · Firm income: $50,000
Matched citations: H.R. 5463
Issues related to making Health Savings Accounts and Health Reimbursement Arrangements more accessible and ubiquitous, including H.R. 548- HSA Modernization Act, H.R.919 - Chronic Disease Flexible Coverage Act, S. 2875 - Custom Health Option and Individual Care Expense (CHOICE) Act, H.R. 5463 - Choice Arrangement Act, S.2875 - CHOICE Act
Client expense: — · Firm income: $50,000
Matched citations: H.R. 548
Chronic Disease Flexible Coverage Act
2026 · third_quarter · Client: WEX HEALTH
Issues related to making Health Savings Accounts and Health Reimbursement Arrangements more accessible and ubiquitous, including H.R. 548- HSA Modernization Act, H.R.919 - Chronic Disease Flexible Coverage Act, S. 2875 - Custom Health Option and Individual Care Expense (CHOICE) Act, H.R. 5463 - Choice Arrangement Act, S.2875 - CHOICE Act
Client expense: — · Firm income: $50,000
Matched citations: H.R.919
Issues related to making Health Savings Accounts and Health Reimbursement Arrangements more accessible and ubiquitous, including H.R. 548- HSA Modernization Act, H.R.919 - Chronic Disease Flexible Coverage Act, S. 2875 - Custom Health Option and Individual Care Expense (CHOICE) Act, H.R. 5463 - Choice Arrangement Act, S.2875 - CHOICE Act
Client expense: — · Firm income: $50,000
Matched citations: S. 2875, S.2875
Skin Substitute Access and Payment Reform Act
2026 · third_quarter · Client: VENTURE MEDICAL
Issues related to coverage of and reimbursement for Human Cell & Tissue products. Skin Substitute Access and Payment Reform Act of 2025 (H.R. 5768/S. 2561). Issues related to skin substitute payment in 2027 Medicare Physician Fee Schedule Proposed Rule (CMS-1848-P) Advanced Wound Care and Regenerative Medicine Access and Reform Act (H.R. 6852)
Client expense: — · Firm income: $30,000
Matched citations: H.R. 5768
Advanced Wound Care and Regenerative Medicine Access and Reform Act
2026 · third_quarter · Client: VENTURE MEDICAL
Issues related to coverage of and reimbursement for Human Cell & Tissue products. Skin Substitute Access and Payment Reform Act of 2025 (H.R. 5768/S. 2561). Issues related to skin substitute payment in 2027 Medicare Physician Fee Schedule Proposed Rule (CMS-1848-P) Advanced Wound Care and Regenerative Medicine Access and Reform Act (H.R. 6852)
Client expense: — · Firm income: $30,000
Matched citations: H.R. 6852
Skin Substitute Access and Payment Reform Act of 2025
2026 · third_quarter · Client: VENTURE MEDICAL
Issues related to coverage of and reimbursement for Human Cell & Tissue products. Skin Substitute Access and Payment Reform Act of 2025 (H.R. 5768/S. 2561). Issues related to skin substitute payment in 2027 Medicare Physician Fee Schedule Proposed Rule (CMS-1848-P) Advanced Wound Care and Regenerative Medicine Access and Reform Act (H.R. 6852)
Client expense: — · Firm income: $30,000
Matched citations: S. 2561
H.R.5269/2761 - RESULTS Act Issues related to Medicare coverage and reimbursement for FDA-designated breakthrough medical devices, focusing on establishing a transitional coverage period, including H.R. 5343/S. 1717- Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Client expense: — · Firm income: $40,000
Matched citations: H.R.5269
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · third_quarter · Client: ROCHE DIAGNOSTICS
H.R.5269/2761 - RESULTS Act Issues related to Medicare coverage and reimbursement for FDA-designated breakthrough medical devices, focusing on establishing a transitional coverage period, including H.R. 5343/S. 1717- Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 5343
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
2026 · third_quarter · Client: ROCHE DIAGNOSTICS
H.R.5269/2761 - RESULTS Act Issues related to Medicare coverage and reimbursement for FDA-designated breakthrough medical devices, focusing on establishing a transitional coverage period, including H.R. 5343/S. 1717- Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Client expense: — · Firm income: $40,000
Matched citations: S. 1717
Methane Waste Prevention Act of 2021
2026 · third_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Access and reimbursement in Medicare Parts B and D. Implementation of provisions included in Subtitle B of PL.117-169- Inflation Reduction Act of 2022. Support for EPIC Act - S. 832, and H.R. 1492, To equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act Policies related to the Most Favored Nation Drug Pricing Model
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1492
Foster Care Stabilization Act
2026 · third_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Access and reimbursement in Medicare Parts B and D. Implementation of provisions included in Subtitle B of PL.117-169- Inflation Reduction Act of 2022. Support for EPIC Act - S. 832, and H.R. 1492, To equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act Policies related to the Most Favored Nation Drug Pricing Model
Client expense: — · Firm income: $60,000
Matched citations: H.R. 4299
Tax Exempt Hospital Transparency Act
2026 · third_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Issues related to the Tax Exempt Hospital Transparency Act (H.R. 9504).
Client expense: — · Firm income: $60,000
Matched citations: H.R. 9504
GREEN Building Jobs Act of 2021
2026 · third_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Access and reimbursement in Medicare Parts B and D. Implementation of provisions included in Subtitle B of PL.117-169- Inflation Reduction Act of 2022. Support for EPIC Act - S. 832, and H.R. 1492, To equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act Policies related to the Most Favored Nation Drug Pricing Model
Client expense: — · Firm income: $60,000
Matched citations: S. 832
H.R. 2168/S.3712, Baby Observation (BO's) Act
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2168
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
2026 · third_quarter · Client: OWLET
Issues related to infant monitoring in H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client expense: — · Firm income: $30,000
Matched citations: H.R.9260
H.R. 2168/S.3712, Baby Observation (BO's) Act
Client expense: — · Firm income: $30,000
Matched citations: S.3712
Emergency Care Improvement Act
2026 · third_quarter · Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC)
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers, including H.R. 3134, the Emergency Care Improvement Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 3134
No Surprises Act Enforcement Act
2026 · third_quarter · Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC)
Issues relating to the implementation of provisions included in Subtitle BB of PL.116-260- No Surprises Act, including the No Surprises Act Enforcement Act (H.R. 4710/S. 2420). Issues relating to the Federal Independent Dispute Resolution Operations proposed rule
Client expense: — · Firm income: $60,000
Matched citations: H.R. 4710
Source: Senate LDA